KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Income from Continuing Operations (2019 - 2025)

GoodRx Holdings' Income from Continuing Operations history spans 7 years, with the latest figure at 5425000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 19.51% year-over-year to 5425000.0; the TTM value through Dec 2025 reached 30439000.0, up 85.72%, while the annual FY2025 figure was 30439000.0, 85.72% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 5425000.0 at GoodRx Holdings, up from 1119000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 58786000.0 in Q2 2023 and bottomed at 41734000.0 in Q3 2022.
  • The 5-year median for Income from Continuing Operations is 1393500.0 (2021), against an average of 1006050.0.
  • The largest YoY upside for Income from Continuing Operations was 4254.49% in 2023 against a maximum downside of 1211.82% in 2023.
  • A 5-year view of Income from Continuing Operations shows it stood at 39914000.0 in 2021, then soared by 95.06% to 1972000.0 in 2022, then crashed by 1211.82% to 25869000.0 in 2023, then skyrocketed by 126.05% to 6740000.0 in 2024, then fell by 19.51% to 5425000.0 in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Income from Continuing Operations are 5425000.0 (Q4 2025), 1119000.0 (Q3 2025), and 12843000.0 (Q2 2025).